Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-transplant Events

Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program

Bone Marrow Transplantation volume 46, pages 137–142 (2011)Cite this article

Subjects

Abstract

Respiratory syncytial virus (RSV) infections can be serious in severely immunocompromised patients. Use of a targeted infection control program (TICP) has been shown to reduce RSV nosocomial transmission. We evaluated the impact of an enhanced seasonal infection control program (ESICP) vs standard TICP in a hematology–oncology ward. TICP was applied from 1999 to 2001 and ESICP applied from 2001 to 2003. ESICP consisted of strict isolation for all patients admitted on the ward during the RSV season. We prospectively evaluated the incidence, related morbidity and mortality of nosocomial RSV in both field interventions. A total of 40 hospitalized RSV infections were documented. The cumulative incidence of nosocomial RSV during TICP and ESICP was respectively of 42.8 and 3.9 cases/1000 admissions (relative risk=0.09). ESICP needed to be implemented on 26 admitted patients on our ward to prevent one RSV nosocomial case. Furthermore, implementation of ESICP prevented four pneumonias and two deaths per RSV season. We conclude that ESICP is significantly more efficient than TICP to reduce the occurrence of nosocomial RSV infections and its related morbidity and mortality in patients with hematological malignancy and recipients of hematopoietic SCT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Chemaly RF, Ghosh S, Bodey GP, Rohatgi N, Safdar A, Keating MJ et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 2006; 85: 278–287.

    Article  Google Scholar 

  2. Ljungman P, Ward KN, Crooks BN, Parker A, Martino R, Shaw PJ et al. Respiratory virus infections after stem cell transplantation: a prospective study from the infectious diseases working party of the european group for blood and marrow transplantation. Bone Marrow Transplant 2001; 28: 479–484.

    Article  CAS  Google Scholar 

  3. Machado CM, Boas LS, Mendes AV, Santos MF, da Rocha IF, Sturaro D et al. Low mortality rates related to respiratory virus infections after bone marrow transplantation. Bone Marrow Transplant 2003; 31: 695–700.

    Article  CAS  Google Scholar 

  4. Ebbert JO, Limper AH . Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome. Respiration 2005; 72: 263–269.

    Article  Google Scholar 

  5. Hassan IA, Chopra R, Swindell R, Mutton KJ . Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience. Bone Marrow Transplant 2003; 32: 73–77.

    Article  CAS  Google Scholar 

  6. Anaissie EJ, Mahfouz TH, Aslan T, Pouli A, Desikan R, Fassas A et al. The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management. Blood 2004; 103: 1611–1617.

    Article  CAS  Google Scholar 

  7. Martino R, Porras RP, Rabella N, Williams JV, Ramila E, Margall N et al. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant 2005; 11: 781–796.

    Article  Google Scholar 

  8. Ison MG . Respiratory syncytial virus and other respiratory viruses in the setting of bone marrow transplantation. Curr Opin Oncol 2009; 21: 171–176.

    Article  CAS  Google Scholar 

  9. Boeckh M, Englund J, Li Y, Miller C, Cross A, Fernandez H et al. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin Infect Dis 2007; 44: 245–249.

    Article  CAS  Google Scholar 

  10. Torres HA, Aguilera EA, Mattiuzzi GN, Cabanillas ME, Rohatgi N, Sepulveda CA et al. Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia. Haematologica 2007; 92: 1216–1223.

    Article  Google Scholar 

  11. Ghosh S, Champlin RE, Englund J, Giralt SA, Rolston K, Raad I et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant 2000; 25: 751–755.

    Article  CAS  Google Scholar 

  12. de Fontbrune FS, Robin M, Porcher R, Scieux C, de Latour RP, Ferry C et al. Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2007; 45: 1019–1024.

    Article  Google Scholar 

  13. Khanna N, Widmer AF, Decker M, Steffen I, Halter J, Heim D et al. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clin Infect Dis 2008; 46: 402–412.

    Article  CAS  Google Scholar 

  14. Boeckh M . The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br J Haematol 2008; 143: 455–467.

    PubMed  PubMed Central  Google Scholar 

  15. Englund JA, Anderson LJ, Rhame FS . Nosocomial transmission of respiratory syncytial virus in immunocompromised adults. J Clin Microbiol 1991; 29: 115–119.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Abdallah A, Rowland KE, Schepetiuk SK, To LB, Bardy P . An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: effect on engraftment and outcome of pneumonia without specific antiviral treatment. Bone Marrow Transplant 2003; 32: 195–203.

    Article  CAS  Google Scholar 

  17. Champlin RE, Whimbey E . Community respiratory virus infections in bone marrow transplant recipients: the MD anderson cancer center experience. Biol Blood Marrow Transplant 2001; 7 (Suppl): 8S–10S.

    Article  Google Scholar 

  18. Garcia R, Raad I, Abi-Said D, Bodey G, Champlin R, Tarrand J et al. Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients. Infect Control Hosp Epidemiol 1997; 18: 412–416.

    Article  CAS  Google Scholar 

  19. Jones BL, Clark S, Curran ET, McNamee S, Horne G, Thakker B et al. Control of an outbreak of respiratory syncytial virus infection in immunocompromised adults. J Hosp Infect 2000; 44: 53–57.

    Article  CAS  Google Scholar 

  20. Raad I, Abbas J, Whimbey E . Infection control of nosocomial respiratory viral disease in the immunocompromised host. Am J Med 1997; 102 (3A): 48–52; discussion 3–4.

    Article  CAS  Google Scholar 

  21. Simon A, Khurana K, Wilkesmann A, Muller A, Engelhart S, Exner M et al. Nosocomial respiratory syncytial virus infection: impact of prospective surveillance and targeted infection control. Int J Hyg Environ Health 2006; 209: 317–324.

    Article  Google Scholar 

  22. Guidelines for prevention of nosocomial pneumonia. Centers for Disease Control and Prevention. MMWR Recomm Rep 1997; 46 (RR-1): 1–79.

    Google Scholar 

  23. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 2000; 49 (RR-10): 1–125 CE1–7.

  24. Machado AF, Sallum MA, Vilas Boas LS, Tateno AF, Machado CM . Molecular characterization of strains of respiratory syncytial virus identified in a hematopoietic stem cell transplant outpatient unit over 2 years: community or nosocomial infection? Biol Blood Marrow Transplant 2008; 14: 1348–1355.

    Article  Google Scholar 

  25. Isaacs D, Dickson H, O’Callaghan C, Sheaves R, Winter A, Moxon ER . Handwashing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus. Arch Dis Child 1991; 66: 227–231.

    Article  CAS  Google Scholar 

  26. Karanfil LV, Conlon M, Lykens K, Masters CF, Forman M, Griffith ME et al. Reducing the rate of nosocomially transmitted respiratory syncytial virus. Am J Infect Control 1999; 27: 91–96.

    Article  CAS  Google Scholar 

  27. Krasinski K, LaCouture R, Holzman RS, Waithe E, Bonk S, Hanna B . Screening for respiratory syncytial virus and assignment to a cohort at admission to reduce nosocomial transmission. J Pediatr 1990; 116: 894–898.

    Article  CAS  Google Scholar 

  28. Leclair JM, Freeman J, Sullivan BF, Crowley CM, Goldmann DA . Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N Engl J Med 1987; 317: 329–334.

    Article  CAS  Google Scholar 

  29. Groothuis J, Bauman J, Malinoski F, Eggleston M . Strategies for prevention of RSV nosocomial infection. J Perinatol 2008; 28: 319–323.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology and Infectious Diseases, Hôpital Sacré-Coeur de Montréal, Montréal, Québec, Canada

    V Lavergne

  2. Department of Immunology and Microbiology, University of Montreal, Montreal, Québec, Canada

    V Lavergne, K Weiss & C Béliveau

  3. Department of Medicine, Hôpital de Verdun, Montréal, Québec, Canada

    M Ghannoum

  4. Department of Microbiology and Infectious Diseases, Hôpital Maisonneuve-Rosemont Montréal, Québec, Canada

    K Weiss & C Béliveau

  5. Department of Hematology and Oncology, Hôpital Maisonneuve-Rosemont Montréal, Québec, Canada

    J Roy

Authors
  1. V Lavergne
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Ghannoum
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Roy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C Béliveau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V Lavergne.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lavergne, V., Ghannoum, M., Weiss, K. et al. Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program. Bone Marrow Transplant 46, 137–142 (2011). https://doi.org/10.1038/bmt.2010.67

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2010.67

Keywords

Search

Advanced search

Quick links